1. Home
  2. AVIR
  3. AVIR News

Latest Atea Pharmaceuticals Inc. (AVIR) News on December 22, 2024

Atea plans Phase 3 study for hepatitis C drug after mid-stage results

BioPharma Dive

18 days ago

Atea plans Phase 3 study for hepatitis C drug after mid-stage results

Thomson Reuters StreetEvents

a year ago

Q3 2023 Atea Pharmaceuticals Inc Earnings Call

Share on Social Networks: